22
OliX Pharma
226950.KQ·KOSDAQSuwon KRFounded 2010100 employees
Micro CapbiotechPublicDermatologyOphthalmology
Platform: RNAi asym si
Market Cap
$0.2B
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (226950.KQ)
Loading 226950.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixazasiran | 226-9000 | Approved | 4 | MDM2 | Thymoma | ||
| Polalucimab | 226-7447 | Phase 2 | 2 | CDK4/6 | AngelmanFabry |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
OliX Pharma trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (7)